An in-depth discussion with Dr. Natasha Sheybani, who is pioneering the use of Focused Ultrasound (FUS) in precision cancer treatment at the University of Virginia. Dr. Sheybani's research focuses on enhancing immunotherapy for brain and breast cancers through innovative, non-invasive techniques. Her efforts to improve glioblastoma patient outcomes by overcoming major treatment barriers, such as the blood-brain barrier, have earned her recognition by the Forbes 30 under 30 in Science Award and many others. This episode delves into the promising future of cancer care, highlighting the collaborative efforts and clinical trials underway at UVA that are bringing us closer to more effective, personalized cancer treatments.--------------Follow Dr. Sheybani on Social Media:Twitter: https://x.com/ndsheybani?s=20LinkedIn: https://www.linkedin.com/in/natasha-sheybani-024439123/Learn about the FUS Cancer Immunotherapy Center: https://med.virginia.edu/uva-focused-ultrasound-cancer-immunotherapy-center/Director & Host: Dasha Tyshlek, StratCraft, Inc. www.strat-craft.comExecutive Producer: David Chen, Managing Director & Instructor of Engineering Design, UVASenior Producer: Hannah Moore, Associate Director, UVA CoulterDesign Director: Carolyn Wagner, Inc. & Link: carolynwagnerinc.comProduced on behalf of Wallace H. Coulter Center for Translational Research at University of Virginia https://engineering.virginia.edu/research/centers-institutes/coulter

Ver todos los episodios